Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innmedis is a Polish medical company specializing in the field of aesthetic medicine and regenerative therapies. The company is a leading provider of advanced medical devices, notably its proprietary Innmedis System for Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) extraction. Their portfolio includes a wide range of products for dermatology, aesthetic medicine, and orthopedics, such as dermal fillers, biorevitalizers, and specialized medical equipment. Innmedis focuses on delivering high-quality, certified solutions to medical professionals to enhance patient outcomes in tissue regeneration and anti-aging treatments. In addition to product distribution, the company provides comprehensive training and educational programs for healthcare practitioners to ensure the effective application of their technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innmedis.